Magnetic iron compounds in neurological disorders

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 183-192

  Dobson, Jon ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Epilepsy; Huntington's disease; Iron; Magnetite; Neurodegenerative; Parkinson's disease

Indexed keywords

IRON DERIVATIVE;

ALZHEIMER DISEASE; EPILEPSY; HUMAN; HUNTINGTON CHOREA; MAGNETISM; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; NEUROTOXICITY; PARKINSON DISEASE; REVIEW;

EID: 1842451930     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.016     Document Type: Review

References (38)

1. HARRISON, P.M. & P. AROSIO. 1996. The ferritins: molecular properties, iron storage function, and cellular regulation. Biochim. Biophys. Acta 1275: 161-203.
2. SMITH, M.A., P.L.R. HARRIS, L.M. SAYRE & G. PERRY. 1997. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94: 9866-9868.
3. LOVELL, M.A., J.D. ROBERTSON, W.J. TEESDALE et al. 1998. Copper, iron, and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 470-502.
4. GOODMAN, L. 1953. Alzheimer's disease - a clinicopathologic analysis of 23 cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 118: 97-130.
5. FISHER, P., M.E. GOTZ, W. DANIELCZYK et al. 1997. Blood transferrin and ferritin in Alzheimer's disease. Life Sci. 60: 2273-2278.
6. LOEFFLER, D.A., J.R. CONNOR, P.L. JUNEAU et al. 1995. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 65: 710-716.
7. SAYRE, L.M., G. PERRY, P.L.R. HARRIS et al. 2000. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74: 270-279.
8. KIRSCHVINK, J.L., A. KOBAYASHI-KIRSCHVINK & B.J. WOODFORD. 1992. Magnetite biomineralization in the human brain. Proc. Natl. Acad. Sci. USA 89: 7683-7687.
9. DUNN, J.R., M. FULLER, J. ZOEGER et al. 1995. Magnetic material in the human hippocampus. Brain Res. Bull. 36: 149-153.
10. DOBSON, J. & P.P. GRASSI. 1996. Magnetic properties of human hippocampal tissue: evaluation of artefact and contamination sources. Brain Res. Bull. 39: 255-259.
11. WILLMORE, L.J., G.W. SYPERT & J.B. MUNSON. 1978. Recurrent seizures induced by cortical iron injection - model of post-traumatic epilepsy. Ann. Neurol, 4: 329-336.
12. ENGSTROM, E.R., L. HILLERED, R. FLINK. et al. 2001. Extracellular amino acid levels measured with intracerebral microdialysis in the model of posttrauraatic epilepsy induced by intracortical iron injection. Epilepsy Res. 43: 135-144.
13. UEDA, Y. & L.J. WILLMORE. 2000. Sequential changes in glutamate transporter protein levels during Fe3+-induced epileptogenesis. Epilepsy Res. 39: 201-209.
14. IKEDA, M. 2001. Iron overload without the C282Y mutation in patients with epilepsy. J. Neurol. Neurosurg. Psychiatry 70: 551-553.
15. 3 causes spontaneous recurrent seizures. Exp. Neurol. 153: 123-137.
16. SCHULTHEISS-GRASSI, P.P. & J. DOBSON. 1999. Magnetic analysis of human brain tissue. BioMetals 12: 67-72.
17. FULLER, M.D., J. DOBSON, H.G. WIESER & S. MOSER. 1995. On the sensitivity of the human brain to magnetic fields: evocation of epileptiform activity. Brain Res. Bull. 36: 155-159.
18. DOBSON, J., T.G. ST. PIERRE, P.P. SCHULTHEISS-GRASSI et al. 2000. Magnetic stimulation of epileptiform activity in mesial temporal lobe epilepsy patients. Brain Res. 868: 386-391.
19. DOBSON, J., T.G. ST. PIERRE, H.G. WIESER & M. FULLER. 2000. Changes in paroxysmal brainwave patterns of epileptics by application of DC magnetic fields. Bioelectromagnetics 21: 94-99.
20. FULLER, M.D. et al. 2003. In preparation.
21. DOBSON, J. 2002. Investigation of age-related variations in biogenic magnetite levels in the human hippocampus. Exp. Brain Res. 144: 122-126.
22. PARDOE, H. & J. DOBSON. 1999. Magnetic iron biomineralization in rat brains: effects of iron loading. BioMetals 12: 77-82.
23. HAUTOT, D., Q.A. PANKHURST, N. KAHN & J. DOBSON. 2003. Preliminary evaluation of nanoscale biogenic magnetite and Alzheimer's disease. Proc. R. Soc. B Biol. Lett. 270: S62-S64.
24. CURTIS, A.R.J. et al. 2001. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28: 350-354.
25. TIMMEL, C.R., U. TILL, B. BROCKLEHURST et al. 1998. Effects of weak magnetic fields on free radical recombination reactions. Mol. Phys. 95: 71-89.
26. SCAIANO, J.C., S. MONAHAN & J. RENAUD. 1997. Dramatic effect of magnetite particles on the dynamics of photogene rated free radicals. Photochem. Photobiol. 65: 759-762.
27. CHIGNELL, C.F. & R.H. SIK. 1998. Effect of magnetite particles on photoinduced and non-photoinduced free radical processes in human erythrocytes. Photochem. Photobiol. 68: 598-601.
28. DOBSON, J., B. GROSS, C. EXLEY et al. 2001. Biomedical applications of biogenic and biocompatible magnetic nanoparticles. In Modern Problems of Cellular and Molecular Biophysics, pp. 121-130. Noyan Tapan/UNESCO. Yerevan.
29. DOBSON, J. 2001. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett. 496: 1-5.
30. QUINTANA, C., M. LANCIN, C. MARHIC et al. 2000. Preliminary high resolution TEM and electron energy loss spectroscopy studies of ferritin cores extracted from brain in patients with neurodegenerative PSP and Alzheimer diseases. Cell. Mol. Biol. 46: 807-820.
31. ZHAO, G., F. BOU-ABDALLAH, P. AROSIO et al. 2003. Multiple pathways for mineral core formation in mammalian apoferritin: the role of hydrogen peroxide. Biochemistry 42: 3142-3150.
32. SELKOE, D.J. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81: 741-766.
33. SCHUBERT, D. & M. CHEVION. 1995. The role of iron in beta amyloid toxicity. Biochem. Biophys. Res. Commun. 216: 702-707.
34. ROTTKAMP, C.A., A.K. RAINA, X. ZHU et al. 2001. Redox-active iron mediates amyloid-β toxicity. Free Radical Biol. Med. 30: 447-450.
35. BISHOP, G.M., S.R. ROBINSON, Q. LIU et al. 2002. Iron: a pathological mediator of Alzheimer's disease. Dev. Neurosci. 24: 184-187.
36. CHETELAT, G. & J.C. BARON. 2003. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage 18: 525-541.
37. SJØGREN, C.E., K. BRILEY-SAEBØ, M. HANSON & C. JOHANSSON. 1994. Magnetic characterization of iron-oxides for magnetic resonance imaging. Magn. Reson. Med. 31: 268-272.
38. PARDOE, H., W. CHUA-ANUSORN, T.G. ST. PIERRE & J. DOBSON. 2003. Detection limits for ferrimagnetic particle concentrations using magnetic resonance imaging-based proton transverse relaxation rate measurements. Phys. Med. Biol. 48: 89-95.